Treatment Resistant Schizophrenia Completed Phase Trials for Nafcillin (DB00607)

Back to Treatment Resistant Schizophrenia

Also known as: Treatment-resistant Schizophrenia / Schizophrenia NOS / Schizophrenic disorders / Dementia praecox / Unspecified schizophrenia (disorder) / Schizophrenic disorders (disorder) / Schizophrenia, unspecified / Unspecified schizophrenia / [X]Schizophrenia, unspecified (disorder) / Unspecified schizophrenia, unspecified state / Schizophrenia / Schizophrenia (disorder) / Schizophrenia NOS (disorder)

Indication	Status	Phase
DBCOND0116884 (Treatment Resistant Schizophrenia)	Completed	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01431326	Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care		Alfentanil (DB00802) Amikacin (DB00479) Aminocaproic acid (DB00513) Bosentan (DB00559) Cefepime (DB01413) Cidofovir (DB00369) Ciprofloxacin (DB00537) Clozapine (DB00363) Fosfomycin (DB00828) Haloperidol (DB00502) Labetalol (DB00598) Lurasidone (DB08815) Methylprednisolone (DB00959) Molindone (DB01618) Nafcillin (DB00607) Nifedipine (DB01115) Oxycodone (DB00497) Pentobarbital (DB00312) Piperacillin (DB00319) Rocuronium (DB00728) Sevelamer (DB00658) Spironolactone (DB00421) Tazobactam (DB01606) Tobramycin (DB00684) Tranexamic acid (DB00302) Vancomycin (DB00512) Vecuronium (DB01339) Warfarin (DB00682) Ziprasidone (DB00246) Zolpidem (DB00425)